Plasma triglyceride levels and body mass index values are the most important determinants of preβ-1 HDL concentrations in patients with various types of primary dyslipidemia

Atherosclerosis

Volumn 208, Issue 2, 2010, Pages 506-511

  Tsimihodimos, Vasilis ^a   Gazi, Irene ^a   Filippatos, Theodosios ^a   Kostapanos, Michael ^a   Lagos, Kostantinos ^a   Kostara, Christina ^a   Tellis, Constantinos C ^b   Elisaf, Moses ^a   Tselepis, Alexandros D ^b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Dyslipidemia; HDL subfractions; Metabolic syndrome; pre 1 HDL

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BODY MASS INDEX; CHOLESTEROL, HDL; DYSLIPIDEMIAS; FEMALE; HUMANS; LIPIDS; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; TRIGLYCERIDES;

EID: 74749100294     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.07.038     Document Type: Article

References (44)

1. Gordon T., Castelli W.P., Hjortland M.C., Kannel W.B., and Dawber T.R. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 62 (1977) 707-714
2. Kontush A., and Chapman M.J. Antiatherogenic small, dense HDL-guardian angel of the arterial wall?. Nat Clin Pract Cardiovasc Med 3 (2006) 144-153
3. Rader D.J. High-density lipoproteins and atherosclerosis. Am J Cardiol 90 (2002) 62i-70i
4. Castro G.R., and Fielding C.J. Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein. Biochemistry 27 (1988) 25-29
5. Francone O.L., Gurakar A., and Fielding C. Distribution and functions of lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in plasma lipoproteins. Evidence for a functional unit containing these activities together with apolipoproteins A-I and D that catalyzes the esterification and transfer of cell-derived cholesterol. J Biol Chem 264 (1989) 7066-7072
6. Barrans A., Jaspard B., Barbaras R., Chap H., Perret B., and Collet X. Pre-beta HDL: structure and metabolism. Biochim Biophys Acta 1300 (1996) 73-85
7. Huang Y., von E.A., and Assmann G. Cell-derived unesterified cholesterol cycles between different HDLs and LDL for its effective esterification in plasma. Arterioscler Thromb 13 (1993) 445-458
8. Miida T., Kawano M., Fielding C.J., and Fielding P.E. Regulation of the concentration of pre beta high-density lipoprotein in normal plasma by cell membranes and lecithin-cholesterol acyltransferase activity. Biochemistry 31 (1992) 11112-11117
9. Fielding C.J., and Fielding P.E. Molecular physiology of reverse cholesterol transport. J Lipid Res 36 (1995) 211-228
10. Connelly M.A., and Williams D.L. Scavenger receptor BI: a scavenger receptor with a mission to transport high density lipoprotein lipids. Curr Opin Lipidol 15 (2004) 287-295
11. Hesler C.B., Swenson T.L., and Tall A.R. Purification and characterization of a human plasma cholesteryl ester transfer protein. J Biol Chem 262 (1987) 2275-2282
12. Gou L., Fu M., Xu Y., Tian Y., Yan B., and Yang L. Alterations of high-density lipoprotein subclasses in endogenous hypertriglyceridemia. Am Heart J 150 (2005) 1039-1045
13. Miida T., Inano K., Yamaguchi T., Tsuda T., and Okada M. LpA-I levels do not reflect pre beta1-HDL levels in human plasma. Atherosclerosis 133 (1997) 221-226
14. Miida T., Yamaguchi T., Tsuda T., and Okada M. High prebeta1-HDL levels in hypercholesterolemia are maintained by probucol but reduced by a low-cholesterol diet. Atherosclerosis 138 (1998) 129-134
15. Miida T., Sakai K., Ozaki K., et al. Bezafibrate increases prebeta 1-HDL at the expense of HDL2b in hypertriglyceridemia. Arterioscler Thromb Vasc Biol 20 (2000) 2428-2433
16. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 (2005) 2735-2752
17. Miida T., Miyazaki O., Nakamura Y., et al. Analytical performance of a sandwich enzyme immunoassay for pre beta 1-HDL in stabilized plasma. J Lipid Res 44 (2003) 645-650
18. Kalogirou M., Tsimihodimos V., Gazi I., et al. Effect of ezetimibe monotherapy on the concentration of lipoprotein subfractions in patients with primary dyslipidaemia. Curr Med Res Opin 23 (2007) 1169-1176
19. Miida T., Obayashi K., Seino U., et al. LCAT-dependent conversion rate is a determinant of plasma prebeta1-HDL concentration in healthy Japanese. Clin Chim Acta 350 (2004) 107-114
20. Kunitake S.T., Mendel C.M., and Hennessy L.K. Interconversion between apolipoprotein A-I-containing lipoproteins of pre-beta and alpha electrophoretic mobilities. J Lipid Res 33 (1992) 1807-1816
21. Francone O.L., Royer L., and Haghpassand M. Increased prebeta-HDL levels, cholesterol efflux, and LCAT-mediated esterification in mice expressing the human cholesteryl ester transfer protein (CETP) and human apolipoprotein A-I (apoA-I) transgenes. J Lipid Res 37 (1996) 1268-1277
22. Barrans A., Collet X., Barbaras R., et al. Hepatic lipase induces the formation of pre-beta 1 high density lipoprotein (HDL) from triacylglycerol-rich HDL2. A study comparing liver perfusion to in vitro incubation with lipases. J Biol Chem 269 (1994) 11572-11577
23. Deckelbaum R.J., Eisenberg S., Oschry Y., Granot E., Sharon I., and Bengtsson-Olivecrona G. Conversion of human plasma high density lipoprotein-2 to high density lipoprotein-3. Roles of neutral lipid exchange and triglyceride lipases. J Biol Chem 261 (1986) 5201-5208
24. Guerin M., Lassel T.S., Le G.W., Farnier M., and Chapman M.J. Action of atorvastatin in combined hyperlipidemia: preferential reduction of cholesteryl ester transfer from HDL to VLDL1 particles. Arterioscler Thromb Vasc Biol 20 (2000) 189-197
25. Guerin M., Egger P., Soudant C., et al. Cholesteryl ester flux from HDL to VLDL-1 is preferentially enhanced in type IIB hyperlipidemia in the postprandial state. J Lipid Res 43 (2002) 1652-1660
26. Lee M., Kim J.Q., Kim J., Oh H., and Park M. Studies on the plasma lipid profiles, and LCAT and CETP activities according to hyperlipoproteinemia phenotypes (HLP). Atherosclerosis 159 (2001) 381-389
27. Lie J., de C.R., Jauhiainen M., et al. Evaluation of phospholipid transfer protein and cholesteryl ester transfer protein as contributors to the generation of pre beta-high-density lipoproteins. Biochem J 360 (2001) 379-385
28. Nakamura Y., Kotite L., Gan Y., Spencer T.A., Fielding C.J., and Fielding P.E. Molecular mechanism of reverse cholesterol transport: reaction of pre-beta-migrating high-density lipoprotein with plasma lecithin/cholesterol acyltransferase. Biochemistry 43 (2004) 14811-14820
29. Jonkers I.J., Smelt A.H., Hattori H., et al. Decreased PLTP mass but elevated PLTP activity linked to insulin resistance in HTG: effects of bezafibrate therapy. J Lipid Res 44 (2003) 1462-1469
30. Sasahara T., Yamashita T., Sviridov D., Fidge N., and Nestel P. Altered properties of high density lipoprotein subfractions in obese subjects. J Lipid Res 38 (1997) 600-611
31. Bajnok L., Seres I., Varga Z., et al. Relationship of endogenous hyperleptinemia to serum paraoxonase 1, cholesteryl ester transfer protein, and lecithin cholesterol acyltransferase in obese individuals. Metabolism 56 (2007) 1542-1549
32. Murdoch S.J., Carr M.C., Hokanson J.E., Brunzell J.D., and Albers J.J. PLTP activity in premenopausal women. Relationship with lipoprotein lipase, HDL, LDL, body fat, and insulin resistance. J Lipid Res 41 (2000) 237-244
33. Dullaart R.P., de V.R., Dallinga-Thie G.M., van T.A., and Sluiter W.J. Plasma cholesteryl ester transfer protein mass and phospholipid transfer protein activity are associated with leptin in type 2 diabetes mellitus. Biochim Biophys Acta 1771 (2007) 113-118
34. Cheung M.C., Brown B.G., Marino Larsen E.K., Frutkin A.D., O'Brien K.D., and Albers J.J. Phospholipid transfer protein activity is associated with inflammatory markers in patients with cardiovascular disease. Biochim Biophys Acta 1762 (2006) 131-137
35. Tan K.C., Shiu S.W., Wong Y., and Tam S. Plasma phospholipid transfer protein activity and subclinical inflammation in type 2 diabetes mellitus. Atherosclerosis 178 (2005) 365-370
36. Dullaart R.P., Groen A.K., Dallinga-Thie G.M., de V.R., Sluiter W.J., and van T.A. Fibroblast cholesterol efflux to plasma from metabolic syndrome subjects is not defective despite low high-density lipoprotein cholesterol. Eur J Endocrinol 158 (2008) 53-60
37. Sviridov D., Miyazaki O., Theodore K., Hoang A., Fukamachi I., and Nestel P. Delineation of the role of pre-beta 1-HDL in cholesterol efflux using isolated pre-beta 1-HDL. Arterioscler Thromb Vasc Biol 22 (2002) 1482-1488
38. Hirayama S., Miida T., Miyazaki O., and Aizawa Y. Pre beta1-HDL concentration is a predictor of carotid atherosclerosis in type 2 diabetic patients. Diabetes Care 30 (2007) 1289-1291
39. Asztalos B.F., Demissie S., Cupples L.A., et al. LpA-I, LpA-I:A-II HDL and CHD-risk: the framingham offspring study and the Veterans Affairs HDL Intervention Trial. Atherosclerosis 188 (2006) 59-67
40. Asztalos B.F., Collins D., Cupples L.A., et al. Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial. Arterioscler Thromb Vasc Biol 25 (2005) 2185-2191
41. Hattori H., Kujiraoka T., Egashira T., et al. Association of coronary heart disease with pre-beta-HDL concentrations in Japanese men. Clin Chem 50 (2004) 589-595
42. Briand O., Nizard F.M., David-Dufilho M., et al. Human free apolipoprotein A-I and artificial pre-beta-high-density lipoprotein inhibit eNOS activity and NO release. Biochim Biophys Acta 1683 (2004) 69-77
43. Ribeiro I.C., Iborra R.T., Neves M.Q., et al. HDL atheroprotection by aerobic exercise training in type 2 diabetes mellitus. Med Sci Sports Exerc 40 (2008) 779-786
44. Shige H., Nestel P., Sviridov D., Noakes M., and Clifton P. Effect of weight reduction on the distribution of apolipoprotein A-I in high-density lipoprotein subfractions in obese non-insulin-dependent diabetic subjects. Metabolism 49 (2000) 1453-1459